These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 19884170)
1. Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Murray LM; Lee S; Bäumer D; Parson SH; Talbot K; Gillingwater TH Hum Mol Genet; 2010 Feb; 19(3):420-33. PubMed ID: 19884170 [TBL] [Abstract][Full Text] [Related]
2. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. Park GH; Maeno-Hikichi Y; Awano T; Landmesser LT; Monani UR J Neurosci; 2010 Sep; 30(36):12005-19. PubMed ID: 20826664 [TBL] [Abstract][Full Text] [Related]
3. Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn Reedich EJ; Kalski M; Armijo N; Cox GA; DiDonato CJ Exp Neurol; 2021 Mar; 337():113587. PubMed ID: 33382987 [TBL] [Abstract][Full Text] [Related]
4. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Murray LM; Comley LH; Thomson D; Parkinson N; Talbot K; Gillingwater TH Hum Mol Genet; 2008 Apr; 17(7):949-62. PubMed ID: 18065780 [TBL] [Abstract][Full Text] [Related]
5. Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration. Arnold WD; Duque S; Iyer CC; Zaworski P; McGovern VL; Taylor SJ; von Herrmann KM; Kobayashi DT; Chen KS; Kolb SJ; Paushkin SV; Burghes AH PLoS One; 2016; 11(12):e0167077. PubMed ID: 27907033 [TBL] [Abstract][Full Text] [Related]
6. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Hua Y; Sahashi K; Rigo F; Hung G; Horev G; Bennett CF; Krainer AR Nature; 2011 Oct; 478(7367):123-6. PubMed ID: 21979052 [TBL] [Abstract][Full Text] [Related]
7. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog. Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872 [TBL] [Abstract][Full Text] [Related]
8. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy. Kannan A; Jiang X; He L; Ahmad S; Gangwani L Brain; 2020 Jan; 143(1):69-93. PubMed ID: 31828288 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy. Murray LM; Beauvais A; Gibeault S; Courtney NL; Kothary R Acta Neuropathol Commun; 2015 Sep; 3():55. PubMed ID: 26374403 [TBL] [Abstract][Full Text] [Related]
10. Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy. Butchbach ME; Singh J; Thorsteinsdóttir M; Saieva L; Slominski E; Thurmond J; Andrésson T; Zhang J; Edwards JD; Simard LR; Pellizzoni L; Jarecki J; Burghes AH; Gurney ME Hum Mol Genet; 2010 Feb; 19(3):454-67. PubMed ID: 19897588 [TBL] [Abstract][Full Text] [Related]
11. What Genetics Has Told Us and How It Can Inform Future Experiments for Spinal Muscular Atrophy, a Perspective. Blatnik AJ; McGovern VL; Burghes AHM Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445199 [TBL] [Abstract][Full Text] [Related]
12. Notch Signaling Mediates Astrocyte Abnormality in Spinal Muscular Atrophy Model Systems. Ohuchi K; Funato M; Yoshino Y; Ando S; Inagaki S; Sato A; Kawase C; Seki J; Saito T; Nishio H; Nakamura S; Shimazawa M; Kaneko H; Hara H Sci Rep; 2019 Mar; 9(1):3701. PubMed ID: 30842449 [TBL] [Abstract][Full Text] [Related]
13. Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. Martinez TL; Kong L; Wang X; Osborne MA; Crowder ME; Van Meerbeke JP; Xu X; Davis C; Wooley J; Goldhamer DJ; Lutz CM; Rich MM; Sumner CJ J Neurosci; 2012 Jun; 32(25):8703-15. PubMed ID: 22723710 [TBL] [Abstract][Full Text] [Related]
14. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Ahmad S; Wang Y; Shaik GM; Burghes AH; Gangwani L Hum Mol Genet; 2012 Jun; 21(12):2745-58. PubMed ID: 22422766 [TBL] [Abstract][Full Text] [Related]
15. Hypothermia improves disease manifestations in SMA mice via SMN augmentation. Tsai LK; Chen CL; Tsai YC; Ting CH; Chien YH; Lee NC; Hwu WL Hum Mol Genet; 2016 Feb; 25(4):631-41. PubMed ID: 26647309 [TBL] [Abstract][Full Text] [Related]
16. Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy. Liu H; Shafey D; Moores JN; Kothary R J Neurosci Res; 2010 Jan; 88(1):111-22. PubMed ID: 19642194 [TBL] [Abstract][Full Text] [Related]
18. Restoration of SMN to Emx-1 expressing cortical neurons is not sufficient to provide benefit to a severe mouse model of Spinal Muscular Atrophy. Taylor AS; Glascock JJ; Rose FF; Lutz C; Lorson CL Transgenic Res; 2013 Oct; 22(5):1029-36. PubMed ID: 23512182 [TBL] [Abstract][Full Text] [Related]
19. Spinal muscular atrophy and the antiapoptotic role of survival of motor neuron (SMN) protein. Anderton RS; Meloni BP; Mastaglia FL; Boulos S Mol Neurobiol; 2013 Apr; 47(2):821-32. PubMed ID: 23315303 [TBL] [Abstract][Full Text] [Related]
20. Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. Feng Z; Ling KK; Zhao X; Zhou C; Karp G; Welch EM; Naryshkin N; Ratni H; Chen KS; Metzger F; Paushkin S; Weetall M; Ko CP Hum Mol Genet; 2016 Mar; 25(5):964-75. PubMed ID: 26758873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]